Posts

Image
Blogger Popup · Ad preview 📔 Blogger Station Your daily dose of ideas • lifestyle • tech 5 tips to grow your blogger audience Rabeprazole is not universally the "best" antiulcerant, as effectiveness varies by patient factors like ulcer type, H. pylori status, and drug tolerance, but it stands out among proton pump inhibitors (PPIs) for certain advantages. Key Strengths Rabeprazole offers a faster onset of acid suppression compared to omeprazole, achieving near-maximal inhibition (91–100%) after the first dose, which speeds duodenal and gastric ulcer healing and symptom relief like pain. Studies show it heals duodenal ulcers at rates similar to or better than omeprazole (e.g., 98% vs. 93% at 4 weeks) with superior daytime pain improvement. Clinical Uses It effectively treats duodenal/gastric ulcers, GERD, and NSAID-induced ulcers, often maintaining healing long-term (e.g., with low-dose a...
Image
Welcome !! Logo Designs Graphics Designs Web Designs You are welcome to Aptech Designers, designed by Pratik from Nepal. Creativity is my passion. Logo describes your details about company. Graphics Design needs vision to create yours unique digital concept. Responsive and All Browser Compatible Dynamic Web Layouts our target.
Image
 

Portable Cleaning Machine

Image
BUY NOW

Universal test

Image
 

COVID19 : Could Hydroxy chloroquine really be the answer ?

 This site is intended for healthcare professionals Medscape Logo News > Medscape News UK COVID-19: Could Hydroxychloroquine Really Be the Answer? Aude Lecrubier March 18, 2020 196   ADD TO EMAIL ALERTS Could the old generic malaria drug hydroxychloroquine (Plaquenil, Sanofi-Aventis, among others), which is also used for the treatment of rheumatic disease, be an essential treatment for COVID-19? This hypothesis, put forward by some, including Professor Didier Raoult of the IHU MÊditerranÊe Infection in Marseille, was dismissed by other eminent infectious disease specialists and dismissed as fake news recently by the Ministry of Health. Yet it resurfaced yesterday with the presentation on YouTube by Prof Raoult of positive results in a non-randomised, unblinded trial of 24 patients. This follows encouraging in vitro results obtained by a Chinese team led by Xueting Yao, from Peking University Third Hospital, Beijing, China, which were published online by t...
āĻ•āϰোāύা āύি⧟ে āĻ­ুāϞ āϤāĻĨ্āϝ āĻ েāĻ•াāĻŦেāύ āϝেāĻ­াāĻŦে : āϏাāϰা āĻŦিāĻļ্āĻŦে āĻĒ্āϰাāĻŖāϘাāϤী āĻ•āϰোāύাāĻ­াāχāϰাāϏ āĻĻ্āϰুāϤ āĻ›ā§œি⧟ে āĻĒ⧜āĻ›ে। āϤাāϰ āϚে⧟েāĻ“ āĻŦেāĻļি āĻ—āϤিāϤে āĻ›ā§œি⧟ে āĻĒ⧜āĻ›ে āĻ•āϰোāύাāĻ­াāχāϰাāϏ āύি⧟ে āύাāύা āĻ­ুāϞ āϤāĻĨ্āϝ। āχāύ্āϟাāϰāύেāϟ āĻ…āύ āĻ•āϰে āĻĢেāϏāĻŦুāĻ•, āĻŽেāϏেāĻž্āϜাāϰ, āϟুāχāϟাāϰ āĻŦা āĻšো⧟াāϟāϏāĻ…্āϝাāĻĒ āĻ–ুāϞāϞেāχ āĻĒিং āĻ•āϰে āϚāϞে āφāϏāĻ›ে āĻ•āϰোāύাāĻ­াāχāϰাāϏ āύি⧟ে āĻ­িāĻĄিāĻ“ āĻŦাāϰ্āϤাāϏāĻš āύাāύা āϧāϰāύেāϰ āĻŦাāϰ্āϤা। āϝাāϰ āĻŦেāĻļিāϰāĻ­াāχ āφāĻĒāύাāĻ•ে āĻŦিāĻ­্āϰাāύ্āϤিāϤে āĻĢেāϞāĻ›ে। āφāϤāĻ™্āĻ•িāϤ āĻ•āϰে āϤুāϞāĻ›ে। āĻ āϏāĻŦ āĻŦাāϰ্āϤাāϰ āĻ…āϧিāĻ•াংāĻļāχ āĻ—ুāϜāĻŦ āĻŦা āĻ­ু⧟া āϤāĻĨ্āϝে āĻ­āϰা। āϤāĻŦে āĻāχ āĻŽুāĻšূāϰ্āϤে āĻ•āϰোāύাāĻ­াāχāϰাāϏ āĻ েāĻ•াāύোāϰ āϏāϰাāϏāϰি āĻ•োāύো āωāĻĒা⧟ āύেāχ। āφāχāϟি āĻŦিāĻļেāώāϜ্āĻžāϰা āĻŦāϞāĻ›েāύ, āĻ•āϰোāύাāĻ­াāχāϰাāϏ āύি⧟ে āĻ›ā§œাāύো āĻ āϏāĻŦ āĻŦাāϰ্āϤা āĻ েāĻ•াāύোāϰ āĻĒāύ্āĻĨা āϰ⧟েāĻ›ে। āφāϰ āϏেāϟা āφāĻĒāύাāϰা āύিāϜেāϰাāχ āĻĒাāϰেāύ। ⧍⧭ āĻŽাāϰ্āϚ āĻļুāĻ•্āϰāĻŦাāϰ āĻŦিāĻŦিāϏি āĻ…āύāϞাāχāύ āĻāĻ• āĻĒ্āϰāϤিāĻŦেāĻĻāύে āĻ•āϰোāύাāĻ­াāχāϰাāϏ āύি⧟ে āĻāϏāĻŦ āĻ­ুāϞ āϤāĻĨ্āϝ, āĻ—ুāϜāĻŦ āĻŦা āφāϤāĻ™্āĻ•িāϤ āĻšāĻ“ā§Ÿাāϰ āĻŽāϤো āϤāĻĨ্āϝ āĻ েāĻ•াāύোāϰ āĻ•িāĻ›ু āωāĻĒা⧟ āĻŦাāϤāϞে āĻĻেāĻ“ā§Ÿা āĻšā§ŸেāĻ›ে। āϏেāĻ–াāύ āĻĨেāĻ•েāχ āĻ•িāĻ›ু āωāĻĒা⧟ āĻāχ āĻĒ্āϰāϤিāĻŦেāĻĻāύে āĻĒ্āϰāĻĨāĻŽ āφāϞোāϰ āĻĒাāĻ āĻ•āĻĻেāϰ āϜāύ্āϝ āϤুāϞে āϧāϰা āĻšāϞো। ā§§. āĻ…āĻĒেāĻ•্āώা āĻ•āϰুāύ, āĻ­াāĻŦুāύ āĻĒāϰিāĻŦাāϰ āĻŦা āĻŦāύ্āϧু-āϏ্āĻŦāϜāύāĻĻেāϰ āϏুāϰāĻ•্āώিāϤ āϰাāĻ–āϤে āφāĻĒāύি āϝেāĻ•োāύো āϤāĻĨ্āϝ āĻĻ্āϰুāϤ āϤাāĻĻেāϰ āĻ•াāĻ›ে āĻĒাāĻ ি⧟ে āĻĻেāύ। āχāĻŽেāχāϞ, āĻšো⧟াāϟāϏāĻ…্āϝাāĻĒ, āĻĢেāϏāĻŦুāĻ• āĻŦা āϟুāχāϟাāϰে āϝāĻ–āύāχ āϏ্āĻŦাāϏ্āĻĨ্āϝ āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āĻŦা āĻ•āϰোāύাāĻ­াāχāϰাāϏ āύি⧟ে āĻ•োāύো āĻĒāϰাāĻŽāϰ্āĻļāĻŽূāϞāĻ• āĻŦাāϰ্āϤা...